By Paul Anthony Taylor
Dr. Rath Health Foundation  

August 24, 2026

A remarkable study published earlier this year shed further light on a side of the pharma industry that continues to receive remarkably little attention from the mainstream/legacy media: the deliberate use of bribery and other corrupt practices to increase drug sales, influence prescribing, and secure favorable treatment from governments and regulators.